Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/305% below fair value
$72.02−0.34 (-0.47%)
Close on Nov 17, 2026Market cap $229.30MP/E 22.0Yield –
Utah Medical Products pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Utah Medical Products's pe ratio was 22.3× on Nov 11, 2026, against 14.2× a year earlier. Over the last 5 years it ranged from 13.0× to 25.9×, with a median of 18.8×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 22.3× | +8.1 |
| 2025 | Dec 31, 2025 | 14.1× | +0.7 |
| 2024 | Dec 31, 2024 | 13.5× | −4.7 |
| 2023 | Dec 29, 2023 | 18.2× | −4.7 |
| 2022 | Dec 30, 2022 | 22.9× | −3.0 |
| 2021 | Dec 31, 2021 | 25.9× | −0.7 |
| 2020 | Dec 31, 2020 | 26.6× | −2.7 |
| 2019 | Dec 31, 2019 | 29.3× | +4.7 |
| 2018 | Dec 31, 2018 | 24.7× | – |
See a number that looks wrong?